Showing results (1151-1160 of 1,443) with videos related to

Sort By:
Pageof 145
Anticancer Research|March 2, 2005
Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinomaJian-Yong Shao, Yu Zhang, Yu-Hong Li, et al.
Blood|December 28, 2007
Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemiaXue-Fei Huang, Shao-Kai Luo, Jie Xu, et al.
Journal of Hepatocellular Carcinoma|December 2, 2024
Efficacy and Safety of Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Inhibitors for Hepatocellular Carcinoma Patients with Extrahepatic Metastases: A Multicenter Retrospective StudyDe-Yi Liu, Yi-Nan Li, Jia-Yi Wu, et al.
Journal of Translational Medicine|December 13, 2012
Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3Lei Zhao, Li-Ru He, Mian Xi, et al.
Frontiers in Immunology|April 24, 2023
Single-cell immune profiling reveals immune responses in oral lichen planusQionghua Li, Fei Wang, Yujie Shi, et al.
Oncotarget|August 29, 2015
Association of CELF2 polymorphism and the prognosis of nasopharyngeal carcinoma in southern Chinese populationYun-Miao Guo, Ming-Xia Sun, Jing Li, et al.
Journal of Medicinal Chemistry|January 30, 2026
Strategic Use of Benzylic Alcohols Reveals Cryptic Hydrogen-Bonding Interactions: Discovery of HBC-12551 as a Potent Noncovalent Bruton's Tyrosine Kinase InhibitorGang Liu, Shuaishuai Liu, Sangwoo Cho, et al.
Cell Death & Disease|January 27, 2019
SHROOM2 inhibits tumor metastasis through RhoA-ROCK pathway-dependent and -independent mechanisms in nasopharyngeal carcinomaJing Yuan, Lin Chen, Jingshu Xiao, et al.
The Science of the Total Environment|November 24, 2019
Variation of airborne DNA mass ratio and fungal diversity in fine particles with day-night difference during an entire winter haze evolution process of Central ChinaXin Zeng, Shaofei Kong, Shurui Zheng, et al.
Journal of Translational Medicine|July 9, 2009
Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIBChun-Yan Li, Bao-Xiu Li, Yi Liang, et al.
Pageof 145